Natera Inc

NTRA remains in a Stage 2 advance with persistent higher-highs and higher-lows above rising EMAs. A recent Bullish Exhaustion pattern highlights waning upside momentum, prompting a pullback into the 9/21 EMA support zone. Pullbacks have occurred on light volume and are being accepted by rising EMAs, offering a favorable entry for continuation. Short-term conditions support buying now, with key risk a failure and close below the 21 EMA signaling deeper correction.

• ↑Q1 2026 revenue rose 39% YoY to $697M, hitting 1 million tests
• ↑Fetal Focus adoption nears 200K run rate, expanding women’s health reach
• ↓Operating expenses up ~25% YoY eroded Q1 margins